L. wang, “Clinical Progress of Targeted KRAS Drugs Combined with Immune Checkpoint Inhibitors in the Treatment of Pancreatic Cancer”, TMBLS, vol. 8, pp. 397–402, Oct. 2025, doi: 10.62051/rq7x6r98.